Estonia proceeding with second HIMARS buy, eyeing ‘28-29 delivery

Estonia intends to purchase a second tranche of M142 HIMARS launchers from the U.S., potentially six more, despite delivery delays and pending Pentagon approval of the Foreign Military Sale; earlier in 2022 Tallinn signed for six HIMARS worth $200 million that were delivered this year. Tallinn expects possible deliveries in 2028–2029, has secured funding in a four‑year defense plan including an extra €2.8 billion (~$3.2 billion) for air defense and deep-strike capabilities, and is also procuring South Korea’s K239 Chunmoo, signaling sustained defense spending but with execution risk tied to production slots and export approvals.

Analysis

Market structure: Estonia’s intent to buy additional HIMARS (with deliveries pushed to 2028–29) reinforces persistent, multi-year demand for Western precision-strike systems and keeps Lockheed Martin (LMT) and other U.S. primes as structural winners for backlog growth and pricing power. Near-term winners also include non-U.S. suppliers (Hanwha) capturing expedited slots — a sign of buyers hedging against U.S. production bottlenecks — while smaller subsystem suppliers face squeeze as primes re-prioritize slots. On cross-assets, sustained NATO defense spend (Estonia’s €2.8bn plan) is modestly inflationary: expect higher real yields over quarters and continued bid for defense equities (+/- CDS tightening for strong balance-sheet primes).

Key Decisions for Investors

• Establish a 2–3% long position in LMT within 30 days using cash equity; target a 15–25% upside over 12 months if Pentagon FMS approvals and Lockheed production cadence improve, and set a hard stop-loss at -10%/trim at +12% to de-risk.
• Buy LMT LEAPS (expiry ~Jan 2028) sized ~1% of portfolio notional, 20–25% OTM call or equivalent call-spread to express multi-year backlog upside while limiting premium; plan to add if formal FMS approval occurs within 90 days.
• Enter a small 1–2% pair trade: long LMT vs short Hanwha Aerospace (012450.KS) 1% notional — thesis: U.S. primes retain long-term pricing/backlog advantages despite near-term Chunmoo wins; rebalance after first Hanwha export delivery (watch delivery date within 6–12 months).
• Deploy a tactical 0.5–1% notional LMT 3–6 month call-spread (buy ~15% OTM, sell ~30% OTM) ahead of anticipated Pentagon FMS decision window (next 60–120 days); if approved, roll/add; if guidance cut >5% or production delays extend past 12 months, close and rotate proceeds to long-term LEAPs.